Design Therapeutics, Inc. SEC filings DSGN
Design Therapeutics, Inc. has 268 filings in SEC EDGAR's recent list, going back to Mar 20, 2020. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 16, 2025 | — |
| CORRESP | Letter to the SEC | May 14, 2025 | — |
| UPLOAD | Letter from the SEC | May 13, 2025 | — |
| DEFR14A | Filing | Apr 30, 2025 | — |
| EFFECT | Filing | May 9, 2022 | — |
| CORRESP | Letter to the SEC | May 5, 2022 | — |
| CORRESP | Letter to the SEC | May 2, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 29, 2022 | — |
| EFFECT | Filing | Mar 25, 2021 | — |
| CERT | Filing | Mar 24, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 24, 2021 | — |
| 8-A12B | Filing | Mar 23, 2021 | — |
| CORRESP | Letter to the SEC | Mar 23, 2021 | — |
| CORRESP | Letter to the SEC | Mar 23, 2021 | — |
| CORRESP | Letter to the SEC | Mar 22, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 18, 2021 | — |
| CORRESP | Letter to the SEC | Mar 16, 2021 | — |
| CORRESP | Letter to the SEC | Mar 5, 2021 | — |
| SEC STAFF LETTER | Filing | Feb 23, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 23, 2021 | — |
| D | Filing | Feb 12, 2021 | — |
| DRS | Filing | Jan 26, 2021 | — |
| D/A | Filing | Jun 3, 2020 | — |
| D | Filing | Mar 20, 2020 | — |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DSGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Carlsbad, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1807120
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.